Bovie Medical, a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, announced that J-Plasma® has been recognized as an Innovation of the Year by The Society of Laparoendoscopic Surgeons (SLS).

SLS is an educational, non-profit organization established to ensure the highest standards for the practice of laparoscopic, endoscopic and minimally invasive surgery. Each year, SLS recognizes the most innovative products of the last 12 months that have a broad application in minimally invasive surgery. J-Plasma® is one of 7 products to receive this recognition in 2014.

Bovie Medical will receive the recognition at the opening ceremony of SLS’ Minimally Invasive Surgery Week Annual Meeting and Endo Expo on Wednesday, September 10, 2014, in Las Vegas.

“We are honored that J-Plasma® has been recognized as an Innovation of the Year by The Society of Laparoendoscopic Surgeons. This prestigious recognition is further evidence of the technological advantages of J-Plasma® and its usefulness to surgeons across a number of different minimally-invasive procedures,” said Robert L. Gershon, Chief Executive Officer of Bovie Medical.

J-Plasma® is a plasma-based surgical product for cutting and coagulation. J-Plasma® utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery.